Laurus News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Laurus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Laurus Today - Breaking & Trending Today
Foram Parekh shares insights on CDMO companies positive outlook post-Covid correction, potential impact of Biosecure Law, concerns about Laurus s earnings improvement, Sun Pharma s specialty sales focus, and recommendations for pharma sector growth with Lupin and Dr Reddy s. ....
With success rates between 60% and 95%, CAR-T therapies are outclassing traditional chemotherapy or immunotherapy drugs for cancer treatment. In India, prominent players are investing in this field. Can costs be brought down to a level that can make these therapies affordable and enable scale? Are there grey areas in research and regulation, and what are the challenges ahead? ....
The pharmaceutical ingredients maker said that its wholly-owned subsidiary, Laurus Synthesis, incorporated a subsidiary by the name of Laurus Ingredients with effect from 9 January 2021.Laurus Ingredients, a step-down subsidiary of Laurus Labs, will undertake ingredients business and will also set up greenfield projects for new synthesis business. The announcement was made after market hours yesterday, 11 January 2021. Laurus Labs consolidated net profit surged 328.4% to Rs 242.27 crore on a 59.9% increase in net sales to Rs 1,138.84 crore in Q2 September 2020 over Q2 September 2019. Shares of Laurus Labs rose 0.50% to Rs 351.90. Laurus Labs is one of the leading manufacturers of API for anti-retroviral (ARV), oncology, cardiovascular, anti-diabetics, anti-asthma, and gastroenterology. ....